Nalmefene Smoking Cessation Study

• Status: Completed
• Trial end date: 2006-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine if nalmefene is safe and effective in smoking cessation.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Somaxon Pharmaceuticals
• Treatments: Nalmefene; Naltrexone

Criteria

Inclusion Criteria:

• Smokers in good general health self reporting more than 15 cigarettes per day

Exclusion Criteria:

-